Jung Kwan Jang, Korea’s top ginseng product manufacturer, said it conducted a seminar focused on the efficacy and safety of red ginseng during the International Conference on the Science of Botanicals, held in Oxford, Miss., from April 15 to 18.The International Conference on the Science of Botanica
GC Biopharma said it has submitted an investigational new drug (IND) application and applied for Fast Track Designation with the U.S. FDA for GC1130A, an intracerebroventricular (ICV) enzyme replacement therapy (ERT) drug for Sanfilippo Syndrome Type A (MPS IIIA), jointly developed with Korean biote
AI solutions developed by Korean medical artificial intelligence companies, including Lunit, have begun to be used in medical sites, raising expectations among market players and the medical community.On Tuesday last week, Lunit, Coreline Soft, and Deepnoid received the results of the National Evide
Celltrion's Remsima (infliximab) line of products continues to demonstrate market impact with expanded prescriptions in five major European countries—the U.K., Germany, France, Spain, and Italy—also known as EU5.According to pharmaceutical market research firm IQVIA, as of the fourth quarter of 2023
HK inno.N's GERD drug K-CAB has expanded its momentum to the Middle East and North Africa region.Starting from China and expanding across Asia and North and South America, K-CAB is increasing its global market dominance by advancing to the Middle East and North Africa markets, according to the compa
Kakao Healthcare said Tuesday that it has signed a business agreement with global food care and catering company OURHOME to develop AI-based ultra-personalized healthcare solutions jointly.Kakao Healthcare CEO Hwang Hee and OURHOME CEO Koo Ji-eun signed the memorandum of understanding at Kakao Healt
Curocell, a chimeric antigen receptor-T (CAR-T) developer, has applied for Anbal-cel, its CAR-T candidate, to be included in the Ministry of Food and Drug Safety (MFDS)’s Advanced Biomedicine Expedited Approval System.The system is designed to facilitate the rapid market entry of innovative medicine
In alignment with Earth Day, an annual event on April 22, Bayer Korea began its annual "Glück for Green" plogging campaign, an initiative designed to foster sustainable practices among its employees. Plogging refers to picking up rubbish while jogging or walkingThis year marks the third installment
Skyrizi (risankizumab) has emerged as a new option for treating palmoplantar pustulosis (PPP), a condition characterized by pustules, exfoliation, and red patches on the palms of the hands and feet that impair quality of life.AbbVie Korea held a media event on Monday to commemorate the approval of i
Korea's largest private equity firm, MBK Partners, has agreed to purchase a majority stake in Geo-Young, the nation's top pharmaceutical distributor, from Blackstone for approximately 1.95 trillion won ($1.4 billion), Seoul Economic Daily said on Monday. This deal marks the largest transaction of it
Boston Scientific said Monday that it has released the BIB System, a balloon for suppressing appetite in the stomach that can help obese patients lose weight, with insurance coverage in Korea. The BIB System is an intragastric appetite suppression balloon for weight loss treatment in patients with a
The importance of early diagnosis of prostate cancer cannot be overstated. According to data from the World Cancer Research Fund International, prostate cancer is the second most common type of cancer among men globally, following lung cancer.Early detection significantly increases treatment options
Plasmapp, a bioplasma deep-tech company, said Monday that it had signed a contract to supply plasma sterilizers to Osstem Implant.Following signing contracts with large global distributors of STERLINK lite plus (STERLINK U510 in overseas brand name) in the U.S. and Japan, Plasmapp successfully signe
Canon Medical Systems Korea said it installed Aquilion Exceed LB, a state-of-the-art low-dose radiation CT (computed tomography) simulation machine, at Yeungnam University Medical Center in Daegu. The latest CT simulation, to be operational from Monday, is the first AI-powered CT simulation in North
Atrial fibrillation (AF) is one of the most common arrhythmias, with a higher prevalence in older adults. It significantly increases the risk of stroke, and the number of patients is increasing with the aging population in many countries, including Korea. Currently, the main anticoagulants used to t
On Monday, EuBiologics announced that it obtained regulatory approval to initiate a phase 1 study for its proprietary herpes zoster vaccine, EuHZV. With the endorsement from the Ministry of Food and Drug Safety, the company's immune modulation technology has broadened its scope from addressing emerg
Polycythemia vera (PV) is a rare, intractable blood cancer in which a somatic mutation in the bone marrow causes the bone marrow to function abnormally and overproduce red blood cells.The abnormal production of blood cells in the bone marrow causes the blood to become thick, which increases the risk
The government has nominated Noh Yun-hong, head of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), to chair the presidential Special Committee for Healthcare Reform.The special committee is composed of a civilian chairman, government members representing six cabinet minist
Professor Jung Mi-hyang of the Department of Cardiology at the Catholic University of Korea St. Mary's Hospital was recently appointed associate editor of the European Journal of Preventive Cardiology.The European Journal of Preventive Cardiology (IF:8.526), the official journal of the European Soci
Four Korean drugmakers have obtained approval for generic versions of Amgen's oral psoriasis treatment, Otezla (apremilast).Daewoong Pharmaceutical, DongKoo Bio&Pharma, Dong-A ST, and Chong Kun Dang will be able to enter the domestic oral psoriasis treatment market abandoned by the original drug.On